309 related articles for article (PubMed ID: 7938873)
1. [The procollagen-III peptide in the clinical surveillance of alcoholic hepatopathy and other chronic hepatopathies].
Pagani A; Pranzo A; Sala N; Galante T
Recenti Prog Med; 1994 Sep; 85(9):425-8. PubMed ID: 7938873
[TBL] [Abstract][Full Text] [Related]
2. [Determination of serum procollagen-III peptide in chronic liver diseases. Clinical usefulness].
Pagani A; Zigliani P; Pranzo A; Galante T
Minerva Med; 1992 Nov; 83(11):715-20. PubMed ID: 1461542
[TBL] [Abstract][Full Text] [Related]
3. [Serum aminoterminal procollagen type-III peptide in the diagnosis of chronic hepatopathies].
Solís-Herruzo JA; Morillas JD; Vargas J; Colina F; Castellano G; Muñoz Yagüe T; Estenoz J
Med Clin (Barc); 1992 May; 99(1):1-5. PubMed ID: 1602891
[TBL] [Abstract][Full Text] [Related]
4. Value of fibrosis markers for staging liver fibrosis in patients with precirrhotic alcoholic liver disease.
Lieber CS; Weiss DG; Paronetto F;
Alcohol Clin Exp Res; 2008 Jun; 32(6):1031-9. PubMed ID: 18422837
[TBL] [Abstract][Full Text] [Related]
5. Tissue inhibitor of metalloproteinase is increased in the serum of precirrhotic and cirrhotic alcoholic patients and can serve as a marker of fibrosis.
Li J; Rosman AS; Leo MA; Nagai Y; Lieber CS
Hepatology; 1994 Jun; 19(6):1418-23. PubMed ID: 8188171
[TBL] [Abstract][Full Text] [Related]
6. Aminoterminal propeptide of type III procollagen in serum in alcoholic liver disease.
Niemelä O; Risteli L; Sotaniemi EA; Risteli J
Gastroenterology; 1983 Aug; 85(2):254-9. PubMed ID: 6602726
[TBL] [Abstract][Full Text] [Related]
7. Procollagen-type III-peptide serum concentrations in chronic persistent and chronic active hepatitis and in cirrhosis of the liver and their diagnostic value.
Raedsch R; Stiehl A; Waldherr R; Mall G; Gmelin K; Götz R; Walker S; Czygan P; Kommerell B
Z Gastroenterol; 1982 Dec; 20(12):738-43. PubMed ID: 7164528
[TBL] [Abstract][Full Text] [Related]
8. Procollagen-type III peptide serum concentrations in alcoholic and non-alcoholic liver disease.
Monarca A; Petrini C; Perolini S; Pozzi F; Adelasco L; Natangelo R; Croce G
Ric Clin Lab; 1985; 15(2):167-71. PubMed ID: 4059796
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of serum laminin P1, procollagen-III peptides, and N-acetyl-beta-glucosaminidase for monitoring the activity of liver fibrosis.
Schneider M; Voss B; Högemann B; Eberhardt G; Gerlach U
Hepatogastroenterology; 1989 Dec; 36(6):506-10. PubMed ID: 2693303
[TBL] [Abstract][Full Text] [Related]
10. [Serum determination of N-terminal peptide of type III procollagen as a marker of fibrotic activity].
García Montes JM; De Bonilla Blánez F; Herrerías Gutiérrez JM
Rev Esp Enferm Apar Dig; 1989 Mar; 75(3):241-5. PubMed ID: 2734469
[TBL] [Abstract][Full Text] [Related]
11. [Comparison of six potential serum markers of hepatic fibrosis in alcoholic disease of the liver].
Grimbert S; Trinchet JC; Hartmann DJ; Munz C; Garnier M; Mal F; Callard P; Beaugrand M
Gastroenterol Clin Biol; 1993; 17(8-9):570-7. PubMed ID: 8253314
[TBL] [Abstract][Full Text] [Related]
12. Procollagen III peptide levels in alcoholic liver disease and primary biliary cirrhosis.
van Zanten RA; van Leeuwen RE; Beukers R; Wilson JH
Neth J Med; 1988 Jun; 32(5-6):278-84. PubMed ID: 3393256
[No Abstract] [Full Text] [Related]
13. Non-invasive monitoring of oxidant stress in alcoholic liver disease.
Pemberton PW; Smith A; Warnes TW
Scand J Gastroenterol; 2005 Sep; 40(9):1102-8. PubMed ID: 16165720
[TBL] [Abstract][Full Text] [Related]
14. [Procollagen peptide in the serum of patients with rheumatoid arthritis and liver diseases].
Bentsen KD; Hørslev-Petersen K; Horn T; Junker P
Ugeskr Laeger; 1986 Aug; 148(32):2011-4. PubMed ID: 3750528
[No Abstract] [Full Text] [Related]
15. [Serum aminoterminal type III procollagen peptide level and killer cell activity in patients with alcoholic liver diseases].
Schnabel R; Jaszovszky S; Bokor M; Garam T
Orv Hetil; 1991 Jul; 132(27):1479-83. PubMed ID: 1956678
[TBL] [Abstract][Full Text] [Related]
16. [Procollagen-III-peptide in the serum of patients with Crohn disease].
Loeschke K; Kaltenthaler P
Z Gastroenterol; 1989 Mar; 27(3):137-9. PubMed ID: 2718533
[TBL] [Abstract][Full Text] [Related]
17. Serum type III procollagen peptide in alcoholic liver disease and idiopathic hemochromatosis: its relationship to hepatic fibrosis, activity of the disease and iron overload.
Colombo M; Annoni G; Donato MF; Conte D; Martines D; Zaramella MG; Bianchi PA; Piperno A; Tiribelli C
Hepatology; 1985; 5(3):475-9. PubMed ID: 3997075
[TBL] [Abstract][Full Text] [Related]
18. [Significance and limitations of the radioimmunologic determination of the aminoterminal peptide of procollagen III in chronic hepatopathies].
Rossi L; Degen C; Lorenzin F; Milani A; Siciliano M
Ann Ital Med Int; 1988; 3(3):203-7. PubMed ID: 3152857
[No Abstract] [Full Text] [Related]
19. [Possibility of early diagnosis of hepatic fibrosis in chronic alcoholics determining the N-terminal peptide of type-III procollagen].
Ricciardi R; Restuccia G
Quad Sclavo Diagn; 1988; 24(1-4):171-8. PubMed ID: 3077474
[TBL] [Abstract][Full Text] [Related]
20. Monitoring patients on methotrexate: hepatic fibrosis not seen in patients with normal serum assays of aminoterminal peptide of type III procollagen.
Maurice PD; Maddox AJ; Green CA; Tatnall F; Schofield JK; Stott DJ
Br J Dermatol; 2005 Mar; 152(3):451-8. PubMed ID: 15787813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
